APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genital Herpes Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Genital Herpes Vaccine Industry Growth and Trends Forecast to 2032

22 December 202591 pages

Choose your research edition.

Industry ResearchGenital Herpes Vaccine Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Genital Herpes Vaccine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Genital Herpes Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genital Herpes Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Genital Herpes Vaccine Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Genital Herpes Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Genital Herpes Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Genital Herpes Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genital Herpes Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Genital Herpes Vaccine include GSK, Changsheng Biotechnology, Merck, Beike Bio and BioNTech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Genital Herpes Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Genital Herpes Vaccine market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Genital Herpes Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Genital Herpes Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Genital Herpes Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Genital Herpes Vaccine Market by Company

GSK

Changsheng Biotechnology

Merck

Beike Bio

BioNTech

Genital Herpes Vaccine Segment by Type

Zoster Vaccine Live

Recombinant Zoster Vaccine

Genital Herpes Vaccine Segment by Application

Male

Female

Genital Herpes Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genital Herpes Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genital Herpes Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genital Herpes Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Genital Herpes Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Genital Herpes Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Zoster Vaccine Live Table 2. Major Company of Recombinant Zoster Vaccine Table 3. Global Genital Herpes Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Genital Herpes Vaccine Sales by Type (2021-2026) & (k units) Table 5. Global Genital Herpes Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Genital Herpes Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Genital Herpes Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global Genital Herpes Vaccine Price by Type (2021-2026) & (US$/unit) Table 9. Global Genital Herpes Vaccine Sales by Type (2027-2032) & (k units) Table 10. Global Genital Herpes Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Genital Herpes Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Genital Herpes Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global Genital Herpes Vaccine Price by Type (2027-2032) & (US$/unit) Table 14. North America Genital Herpes Vaccine Sales by Type (2021-2026) & (k units) Table 15. North America Genital Herpes Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Genital Herpes Vaccine Sales by Type (2021-2026) & (k units) Table 17. Europe Genital Herpes Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Genital Herpes Vaccine Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Genital Herpes Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Genital Herpes Vaccine Sales by Type (2021-2026) & (k units) Table 21. Latin America Genital Herpes Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Genital Herpes Vaccine Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Genital Herpes Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. Genital Herpes Vaccine Industry Trends Table 25. Genital Herpes Vaccine Industry Drivers Table 26. Genital Herpes Vaccine Industry Opportunities and Challenges Table 27. Genital Herpes Vaccine Industry Restraints Table 28. Global Genital Herpes Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Genital Herpes Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global Genital Herpes Vaccine Sales by Company (2021-2026) & (k units) Table 31. Global Genital Herpes Vaccine Sales Share by Company (2021-2026) Table 32. Global Genital Herpes Vaccine Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Genital Herpes Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Genital Herpes Vaccine Major Company Production Sites and Headquarters Table 35. Global Genital Herpes Vaccine Company, Product Type & Application Table 36. Global Genital Herpes Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Genital Herpes Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Genital Herpes Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Genital Herpes Vaccine Sales by Region (2021-2026) & (k units) Table 41. Global Genital Herpes Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Genital Herpes Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Genital Herpes Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global Genital Herpes Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Genital Herpes Vaccine Sales by Region (2027-2032) & (k units) Table 46. Global Genital Herpes Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Genital Herpes Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Genital Herpes Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global Genital Herpes Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Genital Herpes Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Genital Herpes Vaccine Sales by Application (2021-2026) & (k units) Table 52. Global Genital Herpes Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Genital Herpes Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Genital Herpes Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global Genital Herpes Vaccine Price by Application (2021-2026) & (US$/unit) Table 56. Global Genital Herpes Vaccine Sales by Application (2027-2032) & (k units) Table 57. Global Genital Herpes Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Genital Herpes Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Genital Herpes Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global Genital Herpes Vaccine Price by Application (2027-2032) & (US$/unit) Table 61. North America Genital Herpes Vaccine Sales by Application (2021-2026) & (k units) Table 62. North America Genital Herpes Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Genital Herpes Vaccine Sales by Application (2021-2026) & (k units) Table 64. Europe Genital Herpes Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Genital Herpes Vaccine Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Genital Herpes Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Genital Herpes Vaccine Sales by Application (2021-2026) & (k units) Table 68. Latin America Genital Herpes Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Genital Herpes Vaccine Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Genital Herpes Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. GSK Company Information Table 72. GSK Business Overview Table 73. GSK Genital Herpes Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. GSK Genital Herpes Vaccine Product Portfolio Table 75. GSK Recent Development Table 76. Changsheng Biotechnology Company Information Table 77. Changsheng Biotechnology Business Overview Table 78. Changsheng Biotechnology Genital Herpes Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Changsheng Biotechnology Genital Herpes Vaccine Product Portfolio Table 80. Changsheng Biotechnology Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Genital Herpes Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Merck Genital Herpes Vaccine Product Portfolio Table 85. Merck Recent Development Table 86. Beike Bio Company Information Table 87. Beike Bio Business Overview Table 88. Beike Bio Genital Herpes Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Beike Bio Genital Herpes Vaccine Product Portfolio Table 90. Beike Bio Recent Development Table 91. BioNTech Company Information Table 92. BioNTech Business Overview Table 93. BioNTech Genital Herpes Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. BioNTech Genital Herpes Vaccine Product Portfolio Table 95. BioNTech Recent Development Table 96. North America Genital Herpes Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 97. North America Genital Herpes Vaccine Sales by Country (2021-2026) & (k units) Table 98. North America Genital Herpes Vaccine Sales Market Share by Country (2021-2026) Table 99. North America Genital Herpes Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 100. North America Genital Herpes Vaccine Sales Market Share Forecast by Country (2027-2032) Table 101. North America Genital Herpes Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. North America Genital Herpes Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 103. North America Genital Herpes Vaccine Market Share by Country (2021-2026) Table 104. North America Genital Herpes Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. North America Genital Herpes Vaccine Market Share Forecast by Country (2027-2032) Table 106. Europe Genital Herpes Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 107. Europe Genital Herpes Vaccine Sales by Country (2021-2026) & (k units) Table 108. Europe Genital Herpes Vaccine Sales Market Share by Country (2021-2026) Table 109. Europe Genital Herpes Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 110. Europe Genital Herpes Vaccine Sales Market Share Forecast by Country (2027-2032) Table 111. Europe Genital Herpes Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Europe Genital Herpes Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 113. Europe Genital Herpes Vaccine Market Share by Country (2021-2026) Table 114. Europe Genital Herpes Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Europe Genital Herpes Vaccine Market Share Forecast by Country (2027-2032) Table 116. Asia-Pacific Genital Herpes Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. Asia-Pacific Genital Herpes Vaccine Sales by Country (2021-2026) & (k units) Table 118. Asia-Pacific Genital Herpes Vaccine Sales Market Share by Country (2021-2026) Table 119. Asia-Pacific Genital Herpes Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 120. Asia-Pacific Genital Herpes Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Genital Herpes Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Genital Herpes Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. Asia-Pacific Genital Herpes Vaccine Market Share by Country (2021-2026) Table 124. Asia-Pacific Genital Herpes Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Asia-Pacific Genital Herpes Vaccine Market Share Forecast by Country (2027-2032) Table 126. Latin America Genital Herpes Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Latin America Genital Herpes Vaccine Sales by Country (2021-2026) & (k units) Table 128. Latin America Genital Herpes Vaccine Sales Market Share by Country (2021-2026) Table 129. Latin America Genital Herpes Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 130. Latin America Genital Herpes Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Latin America Genital Herpes Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Latin America Genital Herpes Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Latin America Genital Herpes Vaccine Market Share by Country (2021-2026) Table 134. Latin America Genital Herpes Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Latin America Genital Herpes Vaccine Market Share Forecast by Country (2027-2032) Table 136. Middle East and Africa Genital Herpes Vaccine Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Middle East and Africa Genital Herpes Vaccine Sales by Country (2021-2026) & (k units) Table 138. Middle East and Africa Genital Herpes Vaccine Sales Market Share by Country (2021-2026) Table 139. Middle East and Africa Genital Herpes Vaccine Sales Forecast by Country (2027-2032) & (k units) Table 140. Middle East and Africa Genital Herpes Vaccine Sales Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Genital Herpes Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Genital Herpes Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 143. Middle East and Africa Genital Herpes Vaccine Market Share by Country (2021-2026) Table 144. Middle East and Africa Genital Herpes Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Middle East and Africa Genital Herpes Vaccine Market Share Forecast by Country (2027-2032) Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Genital Herpes Vaccine Distributors List Table 149. Genital Herpes Vaccine Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Genital Herpes Vaccine Image Figure 2. Global Genital Herpes Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genital Herpes Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Genital Herpes Vaccine Sales (2021-2032) & (k units) Figure 5. Zoster Vaccine Live Image Figure 6. Global Zoster Vaccine Live Sales YoY Growth (2021-2032) & (k units) Figure 7. Recombinant Zoster Vaccine Image Figure 8. Global Recombinant Zoster Vaccine Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Genital Herpes Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Genital Herpes Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America Genital Herpes Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America Genital Herpes Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe Genital Herpes Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Genital Herpes Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Genital Herpes Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Genital Herpes Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Genital Herpes Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Genital Herpes Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Genital Herpes Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Genital Herpes Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Genital Herpes Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Male Image Figure 24. Global Male Sales YoY Growth (2021-2032) & (k units) Figure 25. Female Image Figure 26. Global Female Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Genital Herpes Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Genital Herpes Vaccine Market Share by Application 2025 VS 2032 Figure 29. North America Genital Herpes Vaccine Sales Market Share in Volume by Application in 2025 Figure 30. North America Genital Herpes Vaccine Sales Market Share in Value by Application in 2025 Figure 31. Europe Genital Herpes Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Genital Herpes Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Genital Herpes Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Genital Herpes Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Genital Herpes Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Genital Herpes Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Genital Herpes Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Genital Herpes Vaccine Sales Market Share in Value by Application in 2025 Figure 39. North America Genital Herpes Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Genital Herpes Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Genital Herpes Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Genital Herpes Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Genital Herpes Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Genital Herpes Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Genital Herpes Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Genital Herpes Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Genital Herpes Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Genital Herpes Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Genital Herpes Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Genital Herpes Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Genital Herpes Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Genital Herpes Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Genital Herpes Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Genital Herpes Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Genital Herpes Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Genital Herpes Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Genital Herpes Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Genital Herpes Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Genital Herpes Vaccine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Genital Herpes Vaccine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Zoster Vaccine Live
  • Recombinant Zoster Vaccine
Applications
  • Male
  • Female
Companies covered
  • GSK
  • Changsheng Biotechnology
  • Merck
  • Beike Bio
  • BioNTech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Genital Herpes Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Genital Herpes Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Genital Herpes Vaccine Market by Type
  6. 1.3.1 Zoster Vaccine Live
  7. 1.3.2 Recombinant Zoster Vaccine
  8. 1.4 Global Genital Herpes Vaccine Market Size by Type
  9. 1.4.1 Global Genital Herpes Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Genital Herpes Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Genital Herpes Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Genital Herpes Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Genital Herpes Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Genital Herpes Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Genital Herpes Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Genital Herpes Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Genital Herpes Vaccine Industry Trends
  2. 2.2 Genital Herpes Vaccine Industry Drivers
  3. 2.3 Genital Herpes Vaccine Industry Opportunities and Challenges
  4. 2.4 Genital Herpes Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Genital Herpes Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Genital Herpes Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Genital Herpes Vaccine Price (2021-2026)
  4. 3.4 Global Genital Herpes Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Genital Herpes Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Genital Herpes Vaccine Company, Product Type & Application
  7. 3.7 Global Genital Herpes Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Genital Herpes Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Genital Herpes Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Genital Herpes Vaccine Tier 1, Tier 2, and Tier 3
4 Genital Herpes Vaccine Regional Status and Outlook
  1. 4.1 Global Genital Herpes Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Genital Herpes Vaccine Historic Market Size by Region
  3. 4.2.1 Global Genital Herpes Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Genital Herpes Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Genital Herpes Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Genital Herpes Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Genital Herpes Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Genital Herpes Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Genital Herpes Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Genital Herpes Vaccine by Application
  1. 5.1 Genital Herpes Vaccine Market by Application
  2. 5.1.1 Male
  3. 5.1.2 Female
  4. 5.2 Global Genital Herpes Vaccine Market Size by Application
  5. 5.2.1 Global Genital Herpes Vaccine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Genital Herpes Vaccine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Genital Herpes Vaccine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Genital Herpes Vaccine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Genital Herpes Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Genital Herpes Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Genital Herpes Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Genital Herpes Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Genital Herpes Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Genital Herpes Vaccine Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 Changsheng Biotechnology
  8. 6.2.1 Changsheng Biotechnology Company Information
  9. 6.2.2 Changsheng Biotechnology Business Overview
  10. 6.2.3 Changsheng Biotechnology Genital Herpes Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Changsheng Biotechnology Genital Herpes Vaccine Product Portfolio
  12. 6.2.5 Changsheng Biotechnology Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Genital Herpes Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Genital Herpes Vaccine Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Beike Bio
  20. 6.4.1 Beike Bio Company Information
  21. 6.4.2 Beike Bio Business Overview
  22. 6.4.3 Beike Bio Genital Herpes Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Beike Bio Genital Herpes Vaccine Product Portfolio
  24. 6.4.5 Beike Bio Recent Developments
  25. 6.5 BioNTech
  26. 6.5.1 BioNTech Company Information
  27. 6.5.2 BioNTech Business Overview
  28. 6.5.3 BioNTech Genital Herpes Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 BioNTech Genital Herpes Vaccine Product Portfolio
  30. 6.5.5 BioNTech Recent Developments
7 North America by Country
  1. 7.1 North America Genital Herpes Vaccine Sales by Country
  2. 7.1.1 North America Genital Herpes Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Genital Herpes Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Genital Herpes Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Genital Herpes Vaccine Market Size by Country
  6. 7.2.1 North America Genital Herpes Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Genital Herpes Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Genital Herpes Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Genital Herpes Vaccine Sales by Country
  2. 8.1.1 Europe Genital Herpes Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Genital Herpes Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Genital Herpes Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Genital Herpes Vaccine Market Size by Country
  6. 8.2.1 Europe Genital Herpes Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Genital Herpes Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Genital Herpes Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Genital Herpes Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Genital Herpes Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Genital Herpes Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Genital Herpes Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Genital Herpes Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Genital Herpes Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Genital Herpes Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Genital Herpes Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Genital Herpes Vaccine Sales by Country
  2. 10.1.1 South America Genital Herpes Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Genital Herpes Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Genital Herpes Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Genital Herpes Vaccine Market Size by Country
  6. 10.2.1 South America Genital Herpes Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Genital Herpes Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Genital Herpes Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Genital Herpes Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Genital Herpes Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Genital Herpes Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Genital Herpes Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Genital Herpes Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Genital Herpes Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Genital Herpes Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Genital Herpes Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Genital Herpes Vaccine Value Chain Analysis
  2. 12.1.1 Genital Herpes Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Genital Herpes Vaccine Production Mode & Process
  7. 12.2 Genital Herpes Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Genital Herpes Vaccine Distributors
  10. 12.2.3 Genital Herpes Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst